EU
BMRN icon

Emory University’s BioMarin Pharmaceuticals BMRN Stock Holding History

Emory University’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,278
Closed -$2.25M – 25
2019
Q2 		$2.25M Buy
26,278
+902
+4% +$77.2K 1.58% 24
2019
Q1 		$2.25M Buy
25,376
+1,074
+4% +$99.5K 1.58% 24
2018
Q4 		$2.07M Sell
24,302
-2,638
-10% -$251K 1.63% 20
2018
Q3 		$2.61M Sell
26,940
-3,250
-11% -$324K 1.71% 20
2018
Q2 		$2.84M Sell
30,190
-633
-2% -$55.4K 1.89% 10
2018
Q1 		$2.5M Buy
30,823
+8,686
+39% +$745K 1.78% 21
2017
Q4 		$1.97M Buy
22,137
+2,354
+12% +$205K 1.69% 19
2017
Q3 		$1.84M Buy
19,783
+2,453
+14% +$217K 1.46% 17
2017
Q2 		$1.57M Sell
17,330
-6,461
-27% -$588K 1.39% 36
2017
Q1 		$2.09M Buy
23,791
+744
+3% +$66.2K 1.97% 14
2016
Q4 		$1.91M Buy
+23,047
New +$1.98M 1.88% 13
2015
Q3 		$1.18M Sell
11,155
-1,012
-8% -$135K 3.27% 20
2015
Q2 		$1.66M Buy
12,167
+2,452
+25% +$304K 2.25% 6
2015
Q1 		$1.21M Buy
+9,715
New +$1.03M 2.29% 3
2014
Q1 		– Sell
-100
Closed -$7K – 22
2013
Q4 		$7K Hold
100
– – ﹤0.01% 66
2013
Q3 		$7K Hold
100
– – ﹤0.01% 65
2013
Q2 		$6K Buy
+100
New +$6.23K ﹤0.01% 73

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Emory University's BMRN Position: Q3 2019 in Review

Emory University sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2019, closing a stake of 26,278 shares — an estimated $2.25M sold.

Emory University first reported a position in BMRN in Q2 2013 and held it in 17 quarters. The position peaked at $2.84M in Q2 2018. 436 funds tracked by Wall St. Rank hold BMRN as of Q3 2019.

  • Emory University reported no remaining BioMarin Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Emory University sold 26,278 BioMarin Pharmaceuticals shares in Q3 2019, an estimated $2.25M.
  • Emory University first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Emory University's BioMarin Pharmaceuticals position peaked at $2.84M in Q2 2018.
  • 436 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2019.

Based on Emory University's 13F filing for Q3 2019, filed 14 Nov 2019.